| 000 | 01283 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516020403.0 | ||
| 264 | 0 | _c20110727 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1517/14728222.2011.547480 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuff, Christopher J | |
| 245 | 0 | 0 |
_aPCSK9: an emerging target for treatment of hypercholesterolemia. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _cFeb 2011 |
||
| 300 |
_a157-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aProprotein Convertase 9 |
| 650 | 0 | 4 | _aProprotein Convertases |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xgenetics |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xpharmacology |
| 700 | 1 | _aHooper, Nigel M | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 15 _gno. 2 _gp. 157-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728222.2011.547480 _zAvailable from publisher's website |
| 999 |
_c20490460 _d20490460 |
||